May 18, 2022
Cyber News
AstraZeneca buys into startup RQ Bio's COVID antibodies & & pharmaphorum
AstraZeneca buys into startup RQ Bio's COVID antibodies - pharmaphorum... See more »
BMS: Bristol Myers plays it safe with first Zeposia TV ad for ulcerative colitis
Bristol Myers plays it safe with first Zeposia TV ad for ulcerative colitis badams Fri, 01/14/2022 - 07:55
Read full article »May 17, 2022
MarketWatch
The Wall Street Journal: Pfizer's Covid-19 booster shot cleared for children ages 5 to 11
U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and Bi... See more »
May 17, 2022
Medthority
FDA lifts clinical hold on investigational lenacapavir for the treatment and prevention of HIV.
Gilead Sciences, Inc. announced the FDA has lifted the clinical hold placed on the company's Investig... See more »
May 17, 2022Endpoints News
A long time coming: GlaxoSmithKline officially changes name to GSK
Shorter is better, at least according to GlaxoSmithKline, which officially changed its name on Monday... See more »
May 17, 2022Pharamceutical Technology
AbbVie to licence Cugene's therapies for autoimmune diseases
Under the deal, AbbVie will make an upfront payment of $48.5m to Cugene. The post AbbVie to licence C... See more »
May 18, 2022Outsourcing-Pharma
Lilly deploys AI-powered tech to expedite drug approval process
The pharmaceutical company is partnering with Yseop to install the software companyâs Augmented Analy... See more »
May 18, 2022Endpoints News
Under-the-radar Chinese biotech scores $47M upfront in secretive Merck deal around cancer drug
During his most recent investor call, Merck CEO Rob Davis promised to be "appropriately aggressive in... See more »
May 18, 2022Business Recorder
Abbott Laboratories (Pakistan) Limited
Abbott Laboratories (Pakistan) Limited (PSX: ABOT) was established as a public limited company in 194... See more »
May 18, 2022FierceBiotech
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer aliu Wed, 05/18/... See more »
May 18, 2022
Cyber News
AstraZeneca buys into startup RQ Bio's COVID antibodies & & pharmaphorum
AstraZeneca buys into startup RQ Bio's COVID antibodies - pharmaphorum... See more »
May 17, 2022
MarketWatch
The Wall Street Journal: Pfizer's Covid-19 booster shot cleared for children ages 5 to 11
U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and Bi... See more »
May 17, 2022
Medthority
FDA lifts clinical hold on investigational lenacapavir for the treatment and prevention of HIV.
Gilead Sciences, Inc. announced the FDA has lifted the clinical hold placed on the company's Investig... See more »
May 17, 2022Endpoints News
A long time coming: GlaxoSmithKline officially changes name to GSK
Shorter is better, at least according to GlaxoSmithKline, which officially changed its name on Monday... See more »
May 17, 2022Pharamceutical Technology
AbbVie to licence Cugene's therapies for autoimmune diseases
Under the deal, AbbVie will make an upfront payment of $48.5m to Cugene. The post AbbVie to licence C... See more »
May 18, 2022Outsourcing-Pharma
Lilly deploys AI-powered tech to expedite drug approval process
The pharmaceutical company is partnering with Yseop to install the software companyâs Augmented Analy... See more »
May 18, 2022Endpoints News
Under-the-radar Chinese biotech scores $47M upfront in secretive Merck deal around cancer drug
During his most recent investor call, Merck CEO Rob Davis promised to be "appropriately aggressive in... See more »
May 18, 2022Business Recorder
Abbott Laboratories (Pakistan) Limited
Abbott Laboratories (Pakistan) Limited (PSX: ABOT) was established as a public limited company in 194... See more »
May 18, 2022FierceBiotech
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer
How Amgen and AstraZeneca's asthma drug Tezspire holds promise for colorectal cancer aliu Wed, 05/18/... See more »
Chairman & CEO
Giovanni Caforio
Bristol-Myers Squibb is a biopharmaceutical firm that discovers, develops and delivers medicines for patients prevail over serious diseases.
Read more